Antiviral drug trial for idiopathic trigeminal neuralgia
Part of Brain & nervous system, Mouth & dental clinical trials.
This trial tests whether an oral antiviral medication can reduce pain in people diagnosed with idiopathic trigeminal neuralgia (pain from the trigeminal nerve with no clear cause). If you have this condition and no other major health problems, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with idiopathic trigeminal neuralgia by a doctor.
- Brain imaging has not found another cause for your pain.
- You do not have a severe disease affecting your liver or kidneys, or a weakened immune system.
- You are able to complete questionnaires on your own.
- You are not pregnant or breastfeeding.
- You agree to take part and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding electroacupuncture to your current medication can better control trigeminal neuralgia pain and reduce side effects. You should already be taking carbamazepine or oxcarbazepine.
This trial tests whether adding electroacupuncture (a type of acupuncture with mild electric current) helps reduce facial pain in people with trigeminal neuralgia. It may help if you are already on carbamazepine medicine but still have pain.
This trial tests whether adding pregabalin to your usual carbamazepine treatment can better control trigeminal neuralgia pain. It is for people with classic trigeminal neuralgia who want to see if a combination of medicines can help.
This trial tests a treatment called trigger point bloodletting, which uses tiny pricks at specific spots on the upper lip to relieve facial pain from trigeminal neuralgia. It may help reduce pain and improve quality of life for people with this condition.
This trial tests two image-guided procedures to treat severe facial pain from trigeminal neuralgia. It compares using a CT scan versus an X-ray video to guide a needle that heats the nerve to stop pain signals.
This trial tests a new drug called RP-008 combined with varenicline (a quit-smoking medication) to relieve severe facial pain from trigeminal neuralgia. If you've already tried standard pain medications without enough relief, this combination might help reduce your pain attacks.
Hear when a new Idiopathic Trigeminal Neuralgia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.